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Viruses-like particles (VLPs) are frequently being used as platforms for polyvalent display of foreign epitopes
of interest on their capsid surface to improve their presentation enhancing the antigenicity and host immune
response. In the present study, we used the VLPs of Tomato bushy stunt virus (TBSV), an icosahedral plant
virus, as a platform to display 180 copies of 16 amino acid epitopes of ricin toxin fused to the C-terminal end
of a modified TBSV capsid protein (NΔ52). Expression of the chimeric recombinant protein in insect cells
resulted in spontaneous assembly of VLPs displaying the ricin epitope. Cryo-electron microscopy and image
reconstruction of the chimeric VLPs at 22 Å resolution revealed the locations and orientation of the ricin
epitope exposed on the TBSV capsid surface. Furthermore, injection of chimeric VLPs into mice generated
antisera that detected the native ricin toxin. The ease of fusing of short peptides of 15–20 residues and their
ability to form two kinds (T=1, T=3) of bio-nanoparticles that result in the display of 60 or 180 copies of
less constrained and highly exposed antigenic epitopes makes TBSV an attractive and versatile display
platform for vaccine design.
© 2009 Elsevier Inc. All rights reserved.
Introduction
It has been previously described that antigen density greatly
influences the magnitude of antibody response (Bachmann et al.,
1993; Dintzis et al., 1976; Milich et al., 1997). High-density of antigens
can be achieved by attaching antigenic epitopes to the viral coat
protein (CP) subunits, thus generating virus-like particles (VLPs) that
display the chosen epitopes. Virus capsids in general are natural
multivalent assemblies composed of multiple copies, ranging from 60
to 1000s, of one or few kinds of CPs. A variety of VLPs from diverse
sources are being used as polyvalent display platforms (Manchester
and Singh, 2006). VLPs displaying epitopes of interest on their
external surfaces are being explored as candidate vaccines and/or as
therapeutics agents against microbial diseases (Jegerlehner et al.,
2002; Khor et al., 2002; Ludwig and Wagner, 2007; Manayani et al.,
2007; Peabody et al., 2008; Shivachandra et al., 2007).
A number of simple viruses such as cowpea mosaic virus (CPMV),
Flock House virus (FHV) and bacteriophage MS2 have been utilized to
display peptides of interest on the viral surfaces by inserting them into
exposed loops of the respective CP subunits (Khor et al., 2002;
Manayani et al., 2007; Porta et al., 1994). In addition, complex
assemblies like bacteriophage T4 are being use to display foreign
molecules of interest (Fokine et al., 2007; Li et al., 2007; Shivachandra
et al., 2007). In the case of simple viruses such as CPMV and FHV, the
inserted epitopes often undergo proteolytic cleavage resulting in
unanticipated problems. Unlike these cases, TBSV provides a unique
display platform as the peptides of interest could be fused at the end of
C-terminus, which is surface exposed and displayed as linear peptides,
which are free to adopt one or more of their native conformation(s).
Tomato bushy stunt virus (TBSV) is a spherical plant virus that
belongs to the family of Tombusviridae. The three-dimensional
structure of TBSV is available at 2.9 Å resolution (Harrison et al.,
1978; Olson et al., 1983). The native capsids of TBSV are ∼320 Å in
diameter and are composed of 180 copies of a single 41 kDa CP subunit
arranged with T=3 icosahedral symmetry. Tertiary structure of the
TBSV-CP subunit consists of 3 domains. The N-terminal R-domain,
located at the interior of the capsid, interacts with the encapsidated
RNA. This is followed by a shell (S) domain, which forms the
contiguous shell of the capsid and a C-terminal protruding (P) domain
exposed on the capsid exterior (Fig. 1). In the case of TBSV, the display
of foreign epitopes is accomplished by genetically appending the
peptides of interest to the C-terminus of the CP, which results in the
display of peptides on the capsid surface. This was earlier demon-
strated by generating the chimeric capsids of TBSV, expressed in
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plants, by displaying a short peptide of 13 a.a. from GP120 of HIV
(Joelson et al., 1997).
The overall goal of this study was to generate a potential vaccine
for ricin toxin, which remains a common bio-terrorism agent. We
report here successful generation of T=3 chimeric capsids (VLPs) of
TBSV, in insect cells using a baculovirus expression system, displaying
180 copies of a 16 a.a. epitope from the ricin toxin A-chain (RTA) and
their efficacy in eliciting immune response in mice against the ricin
toxin. Furthermore, Cryo-electron microscopy reconstruction of the
chimeric particles of TBSV-RTA peptide revealed the locations and
their relative orientation (presentation) of the ricin peptide(s) on the
capsid surface of TBSV.
Results
Fusion of ricin epitope to the C-terminus of TBSV capsid protein and
assembly of chimeric TBSV-RTA VLPs
Cloning and expression of N-terminal deletion mutants of TBSV
have been described previously (Hsu et al., 2006). One of the deletion
mutants, NΔ52-TBSV, which lacks the N-terminal 52 amino acids of
the TBSV coat protein (CP) yet efficiently forms T=3 particles (Hsu et
al., 2006) was sub-cloned and fused with a 16 amino acid epitope
(residues 95–110) of the ricin toxin A-chain (RTA) at the C-terminus
(Fig. 1). The crystal structure of TBSV clearly indicated that the C-
terminus of TBSV is free and exposed on the capsid surface (Harrison
et al., 1978; Olson et al., 1983). Hence, fusion of the peptide of interest
at the C-terminal end allows the display of the peptide on the outer
capsid surface. Using homologous recombination with linearized
baculovirus genome, a recombinant baculovirus (VSR-20) was
generated, which resulted in the expression of the chimeric protein,
TBSV-RTA16 (TBSV-NΔ52-16 a.a. ricin epitope) and assembly of virus
like particles (VLPs). The chimeric (VLPs) expressing ricin epitope
were purified by pelleting the particles onto 30% sucrose cushion and
further purified on 10–40% sucrose gradients. The purified TBSV-
RTA16 VLPs were analyzed on a 10% Tris–glycine SDS-PAGE, which
showed a single band of approximately 37 kDa protein (Fig. 2A, lane
2). Western blot analysis of TBSV-NΔ72 (a 72 residue N-terminal
deletion mutant of TBSV-CP) and TBSV-RTA16 VLPs was performed
with antibodies raised against denatured TBSV-CP or polyclonal
antibodies raised against ricin toxin. The TBSV-NΔ72 as well as the
TBSV-RTA16 proteins were recognized by the antisera against the
TBSV-CP (Fig. 2B). Both the monomers and dimers of TBSV-NΔ72 and
TBSV-RTA16 CPs were detected strongly, whereas unresolved oligo-
mers of TBSV-CPs were seen as a smear at the top of the blot (Fig 2B,
lanes 1&2). It is interesting to note that the TBSV-CP was detected in
Fig. 1. Schematic presentation of fusion between NΔ52-TBSV capsid protein and 16 amino acid ricin epitopes. (A) Tertiary structure and organization of the individual domains R, S
and P of the TBSV coat protein subunit (B) Schematic presentation of the fusion of 16 a.a. ricin epitope to the C-terminus of TBSV capsid protein. (C) Tertiary structure of the ricin toxin
and the location of 16 amino acid ricin epitopes (red) fused to TBSV-CP. A and B-chains of the ricin toxin are shown in green and magenta, respectively.
Fig. 2. Expression of the TBSV-RTA16 coat protein confirmed using SDS-PAGE andWestern blot analysis. (A) SDS-PAGE analysis of the NΔ72-TBSV protein, chimeric TBSV-RTA16 and
ricin toxin, lane M: Molecular weight markers, lane 1: NΔ72-TBSV protein, lane 2: TBSV-RTA16, lane 3: ricin toxin consists of A and B-chains. (B) Western blot analysis using
polyclonal antisera due to full length TBSV-CP. Description of the lanes is same as in panel A. Monomers and dimers of the TBSV-CPs are identified as ‘m’ and ‘d’ respectively. The
smear at the top of the lanes corresponds to unidentified oligomers of the TBSV-CPs. (C) Western blot analysis using polyclonal antisera against ricin toxin. Description of the lanes is
same as in panel A. Ricin toxin exists as a hetero-dimer of the A and B-chains.
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the Western blots by the antibodies raised against denatured CP but
not the assembled virions. Similar findings have been reported in
previous studies (Joelson et al., 1997). Additionally, the polyclonal
ricin antibody detectedmonomer and dimer forms of TBSV-RTA16 and
the A and B-chains of ricin toxin (Fig. 2C, lanes 2&3) suggesting that
the RTA epitopes are attached to the TBSV-CP upon formation of
chimeric VLPs. It has been shown that the VLPs of TBSV expressed in
the insect cells package cellular RNA suggesting the requirement of
nucleic acid in the formation for TBSV particles (Hsu et al., 2006).
Similar findings have been reported in the case of assembly of
analogous particles of TCV (Stockley et al., 1986). Visualization of VLPs
of TBSV-RTA16 using transmission electron microscopy and negative
staining revealed the presence of homogenous population of particles
similar to that of the parent NΔ52-TBSV particles (Fig. 3).
Cryo-electron microscopic reconstruction of TBSV-TRA VLPs
Cryo-electron microscopy and image reconstruction approach was
employed to identify the location and relative arrangement of the
ricin epitopes on the surface of TBSV. The reconstruction of TBSV-
RTA16 particles at 22 Å resolution confirmed the T=3 icosahedral
arrangement of the chimeric TBSV subunits. The difference maps
between the TBSV-RTA16 reconstruction (maps) and the atomic
model of the TBSV capsid fitted into the EM density and filtered at
22 Å revealed the location of the ricin epitope displayed at the C-
terminus of the TBSV-CP subunit (Fig. 4). Interestingly, the minimum
separation of ∼32 Å is found between the two adjacent epitopes that
come from the icosahedral 2-fold related and quasi 2-fold related C
(C2) and A (A5)-subunits, respectively (Fig. 4B). The epitopes on A-
Fig. 3. Transmission electron micrographs of VLPs of TBSV stained using 1% uranyl acetate (A) NΔ52-TBSV and TBSV-RTA16 VLPs (B). Both kinds of VLPs form approximately similar
size of VLPs (∼35 nm in diameter). Insets show the integrity of VLPs at a higher magnification.
Fig. 4. Cryo-electron microscopy and image reconstruction of TBSV-RTA16 at 22 Å resolution. (A) The electron density of TBSV-CPs is shown in steel blue and the density
corresponding to the ricin peptide is shown in gold. (B) An illustration highlighting the quality of fit of atomic structures of the TBSV-CP and the ricin epitope to the electron density,
which is shown as a transparent surface. Individual epitopes are exposed with a minimum separation of ∼32 Å between two adjacent epitopes, identified by the line with diamonds
at the end, which belong to icosahedral 2-fold related and quasi 2-fold related C and A-subunits respectively. The epitopes of AB(5) and CC(2) dimers are separated by 36 Å and 39 Å
respectively and identified by the lines with arrows, whereas the epitopes of the A, B and C subunits that constitute the reference icosahedral asymmetric unit are separated by ∼85 Å,
identified with the line with spheres at the end. The central triangle (white lines) identifies the icosahedral asymmetric unit. Images were generated using the molecular graphics
program Chimera (Pettersen et al., 2004).
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B5 and C-C2 subunit dimers are separated by ∼36 Å and ∼39 Å
respectively, whereas the epitopes of the A, B and C subunits that
constitute the reference icosahedral asymmetric unit are separated
by ∼85 Å (Fig. 4B).
Immune response against chimeric TBSV-RTA VLPs
The ability of TBSV-RTA16 VLPs to elicit a specific immune
response was evaluated by injecting them into mice. BALB/c mice
were injected with 20 μg of TBSV-RTA VLPs and boosted once after a
week. Sera collected from the mice after 1 week of the second
injection and titer (∼104) was calculated by ELISA (data not shown).
In the Western blot analysis, 25–50 ng of ricin chain-A was readily
detected (Fig. 5B lanes 3–4) by the anti-sera raised against TBSV-
RTA16, demonstrating that the ricin chain-A specific immune
response was elicited by the TBSV-RTA16 VLPs. Anti-sera of TBSV-
RTA16 was able to detect TBSV-RTA16 (Fig. 5B, lane 2) but not the
TBSV-CP (Fig. 5B, lane 1). As noted earlier, the anti-sera raised against
the assembled TBSV capsids did not detect the denatured protein,
suggesting that the anti-sera of TBSV-RTA16 are in fact detecting the
ricin epitope in the blot (Fig. 5B, lane 2).
Discussion
In the present study we have demonstrated the display of 180
copies of the 16 a.a. epitope from the ricin A-chain on the surface of
the TBSV capsid by attaching the peptide to the C-terminus of TBSV
subunit. The VLPs produced using the recombinant baculovirus
system were very stable and could be purified in large quantities.
The assembly of TBSV-RTA16 particles was not affected by the addition
of 16 a.a. peptide at the C-terminus. Cryo-electron microscopy and
image reconstruction of the recombinant VLPs clearly indicated that
the displayed copies of the ricin epitope are highly exposed on the
capsid surface and clearly separated from one another (Fig. 4).
Importantly, the TBSV-RTA16 particles elicited a strong immune
response against ricin epitope when the chimeric VLPs were injected
into mice.
Morris and coworkers (Joelson et al., 1997) reported earlier the
display of a 13 a.a. epitope from GP120 of HIV-1 on the surface of TBSV
by fusing the peptide at the carboxy-end of the TBSV subunit. These
particles were generated in plants and package a full complement of
the entire viral genome, hence are infectious. In the present study,
even though the particles generated in insect cells contain cellular
RNA, it has been shown that there is no full length viral mRNA present
in these particles, thus preventing viral replication (Hsu et al., 2006).
Unlike other VLPs of CPMV, FHV and MS2, where the epitopes are
inserted into loops, TBSV provides a unique display platform as the
peptides of interest could be attached to the C-terminus of the TBSV-
CP that allows the display of the epitopes as linear peptides on the
capsid surface. This in turn allows the epitopes to freely adopt their
one or more native conformations. Furthermore, specific TBSV-CP
subunits (e.g., TBSV-NΔ52, TBSV-NΔ62 or TBSV-NΔ72) can be
selected to generate bio-nanoparticles of appropriate size, T=1
particles of 200 Å in diameter vs. T=3 particles of 350 Å in diameter,
displaying either 60 or 180 copies of epitopes respectively. Together
with the ease of genetically fusing the epitopes of interest to the C-
terminus of the CP makes TBSV a versatile platform for displaying
antigenic epitopes. Polyvalent display of antigens has been proven to
be very effective in eliciting immune response against peptides of
interest (Chackerian et al., 1999, 2008). Thus, the recombinant TBSV-
VLPs could potentially be used as a vaccine platform for various
antigens of interest from variety of pathogens because there would be
no pre-existing immunity against TBSV in animals and humans. We
are in the process of undertaking ricin toxicity challenge experiments
in mice to assess the efficacy of TBSV based polyvalent reagents.
Furthermore, evaluation of scope and possibility of displaying larger
peptides between 30–200 residues is underway.
Materials and methods
Cell culture
Insect cells, Spodoptera frugiperda, (line IPLB-Sf21) were grown in
TC100 medium (Invitrogen, Carlsbad, CA) at 27 °C. Growth media was
supplemented with 0.35 g of NaHCO3 per liter 2.6 g of tryptose broth
per liter, 2 mM L-glutamine, 100 U of penicillin and streptomycin per
mL and 10% heat-inactivated fetal bovine serum. Cultures were
maintained as monolayer in screw-capped plastic flasks or as
suspensions in 1-liter spinner flasks.
Generation of recombinant baculoviruses expressing TBSV-RTA fusion
protein
The cDNA clone of TBSV-CP in plasmid pTCTBcpwas a generous gift
from Drs. T.J. Morris and F. Qu (University of Nebraska, Lincoln,
Nebraska). N-terminal deletion mutants of TBSV capsid proteins
Fig. 5. Detection of TBSV-RTA16 and ricin toxin using the antisera against TBSV-RTA16 VLPs. (A) SDS-PAGE analysis of the TBSV-CPs and ricin toxin, lane M: Molecular weight
markers, lane 1: NΔ72-TBSV protein, lane 2: TBSV-RTA16, lane 3: 25 ng of ricin and lane 4: 50 ng of ricin. (B) Western blot analysis using polyclonal antisera raised against TBSV-
RTA16. Description of the lanes is same as in the panel A. Monomer and dimer forms of TBSV are indicated as ‘m’ and ‘d’ respectively. The A and B-chains of the ricin toxin are
identified accordingly. Only the ricin A-chain is detected in the Western blot analysis, as the displayed (fused) ricin epitope belongs to the A-chain.
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(NΔ52-TBSV, NΔ62-TBSV, NΔ72-TBSV) have been described in
detailed (Hsu et al., 2006). In order to generate chimeric DNA
molecules of NΔ52TBSV-RTA16, the mutant TBSV-CP (NΔ52-TBSV)
sequence and ricin epitope (95–110 amino acids) was PCR amplified
and fused using a standard mutagenic PCR technique (Ho et al., 1989).
Chimeric DNA fragment (NΔ52TBSV-RTA16) was cloned in a TOPO T/
A cloning vector (Invitrogen, CA) and later sequenced to confirm the
accuracy as well as fusion of TBSV and RTA fragment. To facilitate
cloning of chimeric DNA fragment into the multiple cloning site of
pBacPAK9, BamHI and XhoI restriction site sequences were added to
the 5′ and 3′ ends of the NΔ52TBSV-RTA16, respectively and cloned
into a baculovirus transfer vector, pBacPAK9 (Clontech, CA) and
named as VSR15. All the PCR reaction was performed using Platinum
Pfx DNA polymerase (Invitrogen, CA). Recombinant baculoviruses
expressing NΔ52TBSV-RTA16 was generated by co-transfecting VSR15
plasmid constructs with linearized baculovirus DNA into Sf21 insect
cells according to the manufacturer's instructions (Clontech, CA).
Recombinant baculovirus expressing Δ52TBSV-RTA16 was named as
VSR20 and was plaque purified twice and further amplified to obtain
pure stocks with high viral titers.
Protein expression, purification and SDS-PAGE analysis
Sf-21 cells were plated at a density of 8×106 cells per 10 cm tissue
culture dish and were infected with stocks of VSR20 with an MOI of 5
per cell. Cells and supernatant were harvested 72 h post infection.
Nonidet P-40 was added to a final concentration of 1% (v/v) and
incubated on ice for 10min to lyse the cells. Cell debris was pelleted by
centrifugation at 13,800×g for 10 min at 4 °C in a JA17 rotor
(Beckman, Fullerton, CA). The VLPs in the supernatant were pelleted
through a 30% sucrose (wt/wt) cushion by ultracentrifugation at
184,048×g for 2.5 h in a 50.2 Ti rotor (Beckman) at 4 °C. Pellets were
then resuspended in sodium acetate buffer (100 mM Sodium Acetate,
50 mM NaCl, 10 mM CaCl2 and pH 5.5) overnight at 4 °C. Insoluble
material in the resuspended pellet was removed by centrifugation at
12,000×g for 10 min in a micro-centrifuge. To further purify VLPs, the
supernatant was loaded onto 10–40% sucrose gradients (wt/wt)made
in sodium acetate buffer and centrifuged at 197,500 ×g for 2 h in a SW-
41 rotor (Beckman). VLPs were harvested from gradients by punctur-
ing the sides of the tubes with a needle and aspirating the bands using
a syringe or by ISCO gradient fractionator (Teledyne, Los Angeles, CA)
at 0.75 mL/min and 0.5 min per fraction. Purified VLPs were dialyzed
in sodium acetate buffer overnight at 4 °C. The VLPs were
concentrated using Amicon ultra having molecular cut off 100 kDa
(Millipore, USA). Purified VLPs of TBSV-RTA16, NΔ72-TBSV and
purified ricin (positive control for ricin) were resolved on the 10%
Tris–glycin gel (Invitrogen, CA) and stained with simple blue using
manufacturer's instructions (Invitrogen, CA). Gels were documented
using Alpha Imager® gel documentation system (Alpha Innotech,
USA).
Production of hyperimmune antiserum against TBSV-RTA16 and ELISA
To produce hyperimmune serum, mice were immunized with
recombinant TBSV-RTA16 VLPs. The immunization regimen consisted
of one intramuscular injection of the purified CP of TBSV-RTA16 in
Freund's adjuvant (at a dose of 60 μg per mouse) followed by one
booster injection of the same dose in Freund's incomplete adjuvant.
The animals were bled 1 week after the last booster injection. An
enzyme-linked immunosorbent assay (ELISA) was performed to
quantify the titer of antibody. Briefly, the VLPs were directly applied
to microplates (Nun-immuno plates) at 100 μl per well and a final
concentration of 1 μg/mL in carbonate–bicarbonate buffer (0.05M, pH
9.6) and were incubated overnight at 4 °C. The antigen-coated plates
were blocked for 2 h at room temperature with 5% nonfat milk in
0.01 M phosphate-buffered saline (PBS) (pH 7.2) and washed thrice
with PBS containing 0.05% Tween 20 (PBST). Different dilutions of
primary antisera (1:10, 1:100, 1:1,000, and 1:10,000) were incubated
with the antigen for 1 h at room temperature and washed thrice with
PBST. Anti-mouse immunoglobulin (Sigma) was diluted 1:10,000, and
the plates were incubated for 1 h at room temperature. Following
incubation, the plates were washed thrice with PBST, 3,3′,5,5′-
tetramethyl benzidine (TMB)-peroxidase substrate (Sigma) was
added, and the color was allowed to develop for 10 min at room
temperature. The reaction was stopped by adding 1% SDS, and the
optical density at 405 nm was determined with a Spectra Max-250
(Molecular Devices, CA).
Immuno detection of TBSV-RTA16
Protein concentration of purified VLPs of TBSV-RTA16, NΔ72-TBSV
and purified ricin (positive control for ricin) was estimated using BCA
protein assay reagent (Pierce, USA) according to the manufacturer's
instructions. One microgram of protein sample (1 mg/mL) was
diluted in 2× SDS loading buffer (250 mM Tris, pH 6.8, 2% (w/v) SDS,
10% (v/v) glycerol, 100 mM dithiothreitol (DTT), and 0.1% (w/v)
bromophenol blue) and boiled for 2 min. SDS-PAGE was performed
using 10% Tris–glycin gel (Invitrogen, CA). After completion of SDS-
PAGE, gel was electroblotted to PVDF membrane in transfer buffer
(Invitrogen, CA) containing 20%methanol at a constant voltage (30 V)
for 2 h. Prestainedmolecular weight standards (Bio-Rad) were used to
monitor protein transfer. Membranes were blocked for 1 h in blocking
buffer (5% dried milk, 0.1% Tween 20 in PBS) at room temperature and
later incubated at 4 °C overnight in primary antibody against ricin
(Vector Labs, Burlingame, CA) or against TBSV-RTA16, diluted
(1:1000). Membranes were washed for 30 min with 3 changes of
washing buffer (0.1% Tween 20 in PBS), and incubated with HRP-
conjugated secondary antibody, diluted (1:5000 in PBS-Tween 20) for
an hour. After another 30 min wash, with 3 changes of wash buffer,
blot was reacted with SuperSignal chemiluminescent substrates
(Pierce, USA). Blot was exposed on Kodak X-ray films for the
visualization of protein band.
Electron microscopy
Carbon-coated, copper grids were glow discharged in the presence
of amyl acetate immediately before loading samples. Grids were
placed in 10 μL of VLP samples for 1 min, washed three times in sterile
filtered water and stained in 10 μL drops of 1% uranyl acetate three
times allowing the grids to soak in the last drop of stain for 2 min.
After drying grids, samples were examined under an electron
microscope (Phillips CM100).
Cryo-electron microscopy and image reconstruction
Aliquots of the virus suspension at a concentration of about 2–
3 mg/mL were applied to previously glow-discharged Quantifoil EM
grids, which were then blotted and plunged into a bath of liquid
ethane (−180 °C) using Vitrobot from FEI. The grids were then
transferred from liquid nitrogen to a pre-cooled specimen holder
(Gatan) that maintained the frozen hydrated sample at −184 °C in a
Philips Tecnai F20 FEG transmission cryo-electron microscope
operating at 120 kV with a CCD camera. Digital images were recorded
under low-dose conditions (∼10 e/Å2) and those that displayed
minimal astigmatism and drift as assessed by visual inspection and
diffraction were selected for further analysis. Particles clearly
separated from neighbors or background contaminationwere selected
and masked as individual images using the software ROBEM (Baker et
al., 1999). The image intensity values were adjusted to remove linear
background gradients and to normalize the means and variances of
the data. The initial orientation and origin parameters of the images
for the reconstruction were determined by a model based refinement
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approach (Baker et al., 1999). To optimize the search procedure,
calculations were performed using only a portion of the Fourier
transform of themasked image (1/70 Å−1–1/30 Å−1) to remove both
low and high frequency noises. The translation (x,y) and orientation
(0,0,w) parameters were refined for each particle by using repeated
cycles of correlation procedures (Baker et al., 1988, 1991, 1999; Fuller,
1987). Images were typically discarded if they showed a correlation
coefficient calculated between the raw image and the corresponding
projected view of an intermediate reconstruction, greater than one
standard deviation below the mean coefficient of the entire data set.
The final maps were computed based on a total of 342 particles to a
resolution of 22 Å. The resolution of the map was estimated by
dividing the particle images into two sets, generating two reconstruc-
tions and comparing the correlation coefficients and phase residual of
the two sets of structure factors as a function of spatial frequency.
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